Scilex Holding Company
Key Metrics
- Previous Close
- $0.64
- 52-Week Range
- $0.54 – $16.81
- Market Cap
- $4.41M
- P/E (TTM)
- —
- EPS (TTM)
- -49.70
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- —
- PEG Ratio
- —
- Return on Equity
- —
- Return on Assets
- -105.83%
- Gross Margin
- 55.50%
- Operating Margin
- -903.52%
- Profit Margin
- 0.00%
- Current Ratio
- 0.07
- Debt/Equity
- —
- Total Debt
- $105.98M
- Free Cash Flow
- $-8.84M
- Revenue Growth
- -22.80%
- Earnings Growth
- —
- Enterprise Value
- $107.65M
Market Snapshot
About
Scilex Holding Company is a commercial-stage pharmaceutical company focused on acquiring, developing, and commercializing non-opioid pain management products. The company aims to address the unmet needs of patients suffering from acute and chronic pain.